1[2]Remuzzi A,Puntrorieri S,Battaglia C,et al.Angiotensin converting enxyme inhibition ameliorates glomerular filtra-tion of macomolecules and water and lessens glomerular injury in rat.J Clin Invest,1990,85:541-549.
2[3]Alvarez RJ,Sun MJ,Haverty TP,et al.Biosynthetic and proliferative characteristics of tubumointerstitial fibroblasts probed with paracrine cytokines.Kidney Int,1992,41:14-23
3[4]Raiz-Ortega M,Gonzalez S,Seron D,et al.ACE inhibi-tion reduces proteinuria,glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis.Kidney Int,1995,48:1778-1791
4[5]Floege J,Johnson RJ,Gorder K,et al.I creased synthsis of extracellular matrix in mesangial proliferative nephritis Kidney Int,1991,40(3):477-480.
5[6]Border WA.Extracellular matrix and glomerular disease.Seminars in Nephrology,1989,9:307-309.
6Burns KD. Angiotensin Ⅱ and its receptors in the diabetic kidney. Am J Kidtey Dis,2000,36:449.
7Wu LL, Cox A,Roe CJ et al.Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int, 1997,51 : 1553.
8Zoja C, Abbate M, Coma D et al. Pharmacologic control of angiotensin ameliorates renal disease while reducing renal TGF-β in experimental mesangioproliferative glomerulonephritis.Am J Kifnry Dis,1998,31:453.
9Peters H,Border WA, Noble NA. Angiotensin Ⅱ blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis. Kidney Int,2000,57:1493.
10Makarious M, Duggan K, Charlesworth JA et al. Abnormality of the glomerular angiotensin Ⅱ receptor in experimental diabetic nephropathy. Clin Experim Pharmacol Physiol, 1993,20:348.
